Search Results - "Herrem, Christopher J."

Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma by HERREM, Christopher J, TATSUMI, Tomohide, STORKUS, Walter J, OLSON, Kathleen S, SHIRAI, Keisuke, FINKE, James H, BUKOWSKI, Ronald M, MING ZHOU, RICHMOND, Amy L, DERWEESH, Ithaar, KINCH, Michael S

“…Whereas normally expressed at sites of cell-to-cell contact in adult epithelial tissues, recent studies have shown that the receptor tyrosine kinase EphA2 is…”
Get full text

Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma by TATSUMI, Tomohide, HERREM, Christopher J, OLSON, Walter C, FINKE, James H, BUKOWSKI, Ronald M, KINCH, Michael S, RANIERI, Elena, STORKUS, Walter J

“…We have evaluated CD8+ and CD4+ T-cell responses against a new tumor-associated antigen, the receptor tyrosine kinase EphA2, which is broadly expressed in…”
Get full text

Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists by Wesa, Amy K, Herrem, Christopher J, Mandic, Maja, Taylor, Jennifer L, Vasquez, Cecilia, Kawabe, Mayumi, Tatsumi, Tomohide, Leibowitz, Michael S, Finke, James H, Bukowski, Ronald M, Bruckheimer, Elizabeth, Kinch, Michael S, Storkus, Walter J

“…The EphA2 receptor tyrosine kinase is an attractive therapeutic target that is commonly overexpressed on solid tumors, with the degree of overexpression…”
Get full text

Enhancement in Specific CD8+ T cell Recognition of EphA2+ Tumors In Vitro and In Vivo After Treatment with Ligand Agonists1 by Wesa, Amy K., Herrem, Christopher J., Mandic, Maja, Taylor, Jennifer L., Vasquez, Cecilia, Kawabe, Mayumi, Tatsumi, Tomohide, Leibowitz, Michael S., Finke, James H., Bukowski, Ronald M., Bruckheimer, Elizabeth, Kinch, Michael S., Storkus, Walter J.

“…The EphA2 receptor tyrosine kinase (RTK) is an attractive therapeutic target that is commonly overexpressed on solid tumors, with the degree of overexpression…”
Get full text

Characterization and immune targeting of a novel tumor antigen, Epha2 by Herrem, Christopher J

“…In order to generate and monitor effective and specific immune responses against tumors, a clear understanding of relevant tumor antigens and their derivative…”
Get full text